RU2015103107A3 - - Google Patents

Download PDF

Info

Publication number
RU2015103107A3
RU2015103107A3 RU2015103107A RU2015103107A RU2015103107A3 RU 2015103107 A3 RU2015103107 A3 RU 2015103107A3 RU 2015103107 A RU2015103107 A RU 2015103107A RU 2015103107 A RU2015103107 A RU 2015103107A RU 2015103107 A3 RU2015103107 A3 RU 2015103107A3
Authority
RU
Russia
Application number
RU2015103107A
Other versions
RU2015103107A (ru
RU2707089C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46024668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2015103107(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2015103107A publication Critical patent/RU2015103107A/ru
Publication of RU2015103107A3 publication Critical patent/RU2015103107A3/ru
Application granted granted Critical
Publication of RU2707089C2 publication Critical patent/RU2707089C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
RU2015103107A 2010-11-04 2011-10-26 Комбинированная композиция RU2707089C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ58901110 2010-11-04
NZ589011 2010-11-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2013123646/15A Division RU2013123646A (ru) 2010-11-04 2011-10-26 Комбинированная композиция

Publications (3)

Publication Number Publication Date
RU2015103107A RU2015103107A (ru) 2015-06-20
RU2015103107A3 true RU2015103107A3 (ru) 2018-08-20
RU2707089C2 RU2707089C2 (ru) 2019-11-22

Family

ID=46024668

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2013123646/15A RU2013123646A (ru) 2010-11-04 2011-10-26 Комбинированная композиция
RU2015103107A RU2707089C2 (ru) 2010-11-04 2011-10-26 Комбинированная композиция

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2013123646/15A RU2013123646A (ru) 2010-11-04 2011-10-26 Комбинированная композиция

Country Status (27)

Country Link
US (4) US20130225685A1 (ru)
EP (1) EP2635269B1 (ru)
JP (2) JP2013541583A (ru)
KR (1) KR101900520B1 (ru)
CN (2) CN103298464A (ru)
AU (1) AU2011324137B2 (ru)
BR (1) BR112013010829B8 (ru)
CA (1) CA2814057C (ru)
CL (1) CL2013001250A1 (ru)
CO (1) CO6771406A2 (ru)
CY (1) CY1123398T1 (ru)
DK (1) DK2635269T3 (ru)
ES (1) ES2742373T3 (ru)
HR (1) HRP20191489T1 (ru)
HU (1) HUE045442T2 (ru)
LT (1) LT2635269T (ru)
MX (2) MX367209B (ru)
MY (1) MY160572A (ru)
NZ (1) NZ609727A (ru)
PH (1) PH12021550804A1 (ru)
PL (1) PL2635269T3 (ru)
PT (1) PT2635269T (ru)
RS (1) RS59258B1 (ru)
RU (2) RU2013123646A (ru)
SG (1) SG189319A1 (ru)
SI (1) SI2635269T1 (ru)
WO (1) WO2012060719A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814057C (en) 2010-11-04 2022-02-01 Aft Pharmaceuticals Limited Intravenous composition comprising paracetamol and ibuprofen
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CA3069158A1 (en) * 2017-07-10 2019-01-17 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
ES2253326T3 (es) * 2001-11-02 2006-06-01 Cumberland Pharmaceuticals Inc. Composicion farmaceutica de acido 2-(4-isobutilfenilo)propionico.
WO2004093864A1 (en) * 2003-03-21 2004-11-04 Mcneil-Ppc, Inc. Non-steroidal anti-inflammatory drug dosing regimen
US20080275125A1 (en) * 2004-07-07 2008-11-06 Aft Pharmaceuticals Limited Combination Composition
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
WO2008051759A1 (en) * 2006-10-20 2008-05-02 Mcneil-Ppc, Inc. Acetaminophen / ibuprofen combinations
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
JP2012505830A (ja) * 2008-10-14 2012-03-08 エイエフティ ファーマスーティカルズ リミテッド 医薬品及び医薬品治療
ES2823249T3 (es) * 2009-03-12 2021-05-06 Cumberland Pharmaceuticals Inc Administración de ibuprofeno por vía intravenosa
SG186388A1 (en) * 2010-07-07 2013-01-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
CA2814057C (en) 2010-11-04 2022-02-01 Aft Pharmaceuticals Limited Intravenous composition comprising paracetamol and ibuprofen
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛

Also Published As

Publication number Publication date
JP2013541583A (ja) 2013-11-14
WO2012060719A1 (en) 2012-05-10
MY160572A (en) 2017-03-15
LT2635269T (lt) 2019-09-10
JP2017132791A (ja) 2017-08-03
CN103298464A (zh) 2013-09-11
CL2013001250A1 (es) 2013-08-30
KR20140025314A (ko) 2014-03-04
BR112013010829A2 (pt) 2016-08-16
ES2742373T3 (es) 2020-02-14
EP2635269A1 (en) 2013-09-11
PT2635269T (pt) 2019-09-04
HUE045442T2 (hu) 2019-12-30
AU2011324137A1 (en) 2013-05-02
EP2635269A4 (en) 2014-09-17
US20160235695A1 (en) 2016-08-18
US11896567B2 (en) 2024-02-13
JP6353577B2 (ja) 2018-07-04
SI2635269T1 (sl) 2019-10-30
KR101900520B1 (ko) 2018-09-19
CN107519159A (zh) 2017-12-29
US11446266B2 (en) 2022-09-20
RS59258B1 (sr) 2019-10-31
SG189319A1 (en) 2013-05-31
HRP20191489T1 (hr) 2019-11-15
MX2013005113A (es) 2013-06-03
RU2013123646A (ru) 2014-12-10
CY1123398T1 (el) 2021-10-29
US20190029982A1 (en) 2019-01-31
CA2814057C (en) 2022-02-01
BR112013010829B1 (pt) 2021-12-21
CA2814057A1 (en) 2012-05-10
US20230000805A1 (en) 2023-01-05
PL2635269T3 (pl) 2019-11-29
NZ609727A (en) 2015-07-31
RU2015103107A (ru) 2015-06-20
BR112013010829B8 (pt) 2021-12-21
AU2011324137B2 (en) 2015-05-07
DK2635269T3 (da) 2019-08-26
RU2707089C2 (ru) 2019-11-22
EP2635269B1 (en) 2019-05-22
US20130225685A1 (en) 2013-08-29
MX367209B (es) 2019-07-22
PH12021550804A1 (en) 2022-02-14
CO6771406A2 (es) 2013-10-15

Similar Documents

Publication Publication Date Title
BR112013013385A2 (ru)
BR112013008959A2 (ru)
BR112012031500A2 (ru)
BR112012029986A2 (ru)
BR112012024897A2 (ru)
BR112012019354A2 (ru)
BR112012025307A2 (ru)
BR112012002126A2 (ru)
BR112012017960A2 (ru)
BR112013006400A2 (ru)
BR112012031826A2 (ru)
BR112012023249A2 (ru)
BR112012016456A2 (ru)
BR112012025308A2 (ru)
BR112012018256A2 (ru)
BR112012023265A2 (ru)
BR112013010949A2 (ru)
BR112013003284A2 (ru)
BR112013002646A2 (ru)
BR112012022788A2 (ru)
BR112013012726A2 (ru)
BR112012023446A2 (ru)
BR112013006825A2 (ru)
BR112012028859A2 (ru)
BR112012016895A2 (ru)